Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Gynecologic Cancer × Cisplatin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 67 Neoplasms 41 Squamous Cell Carcinoma of Head and Neck 39 Head and Neck Neoplasms 33 Lung Neoplasms 32 Uterine Cervical Neoplasms 26 Stomach Neoplasms 24 Ovarian Neoplasms 24 Unspecified Adult Solid Tumor, Protocol Specific 22 Neoplasm Metastasis 21 Small Cell Lung Carcinoma 19 Pancreatic Neoplasms 18 Colorectal Neoplasms 17 Esophageal Neoplasms 15 Cholangiocarcinoma 15 Carcinoma, Squamous Cell 15 Breast Neoplasms 15 Mesothelioma, Malignant 14 Melanoma 12 Fallopian Tube Neoplasms 11 Carcinoma, Ovarian Epithelial 11 Urinary Bladder Neoplasms 10 Mesothelioma 10 Sarcoma 9 Gallbladder Neoplasms 9 Biliary Tract Neoplasms 9 Esophageal Squamous Cell Carcinoma 8 Carcinoma 8 Peritoneal Neoplasms 7 Colonic Neoplasms 7

Interventions

genexol-PM 1 gadobutrol 1 Population Groups 1 NK Cell Lectin-Like Receptor Subfamily B 1 Exercise 1 Drug Therapy 1 Counseling 1 Cisplatin 1 AGuIX 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03308604 2021-07-07

NANOCOL

Gustave Roussy, Cancer Campus, Grand Paris

Phase 1 Unknown

Gynecologic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡